Faculty profile

Ingrid Spadinger

Back to faculty

Honorary LecturerUBC Physics & AstronomyUniversity of British Columbia

Ingrid Spadinger

Honorary Lecturer

UBC Physics & Astronomy

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
2 publications in the last five years, latest in 2022.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

738

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of British Columbia profile.

Latest papers

Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy.
Journal of gynecologic oncology · 2022
After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis.
Brachytherapy · 2022
Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.
Brachytherapy · 2020 · senior author

All 28 publications

Latest funding

Optimizing the Curative Treatment for High Risk Prostate Cancer: Combining Advanced Imaging, Trans-perineal Mapping Biopsies, and Dual Air Kerma Strength LDR Brachytherapy Implants to Minimize Radiation Dose to Normal Tissues
CIHR · 2016 · Co-investigator
$1,113,078

All 1 grants and awards

28 publications.

Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy.

Urban R, Wong J, Lim P, Zhang S, Spadinger I, Olson R, Bachand F, Ho C, Tinker AV, Gondara L, Hamilton SN

Journal of gynecologic oncology20225 citationsOpen Access

DOI: 10.3802/jgo.2022.33.e70 PMID: 35882607

After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis.

Oh J, Morris WJ, Spadinger I, Tyldesley S, Keyes M, Halperin R, Crook J, Lapointe V, Pickles T

Brachytherapy20222 citations

DOI: 10.1016/j.brachy.2022.05.002 PMID: 35729030

Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.

Golshan M, Mahdavi SS, Samei G, Lobo J, Pickles T, James Morris W, Keyes M, Peacock M, Salcudean SE, Spadinger I

Brachytherapy20203 citationsSenior author

DOI: 10.1016/j.brachy.2020.06.003 PMID: 32682777

Association of bladder dose with late urinary side effects in cervical cancer high-dose-rate brachytherapy.

Zakariaee R, Hamarneh G, Brown CJ, Gaudet M, Aquino-Parsons C, Spadinger I

Brachytherapy201715 citationsSenior author

DOI: 10.1016/j.brachy.2017.07.001 PMID: 28823394

Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity.

Zakariaee R, Hamarneh G, Brown CJ, Gaudet M, Aquino-Parsons C, Spadinger I

Physics in medicine and biology201611 citationsSenior author

DOI: 10.1088/0031-9155/61/24/8408 PMID: 27845913

Source strength verification and quality assurance of preloaded brachytherapy needles using a CMOS flat panel detector.

Golshan M, Spadinger I, Chng N

Medical physics2016

DOI: 10.1118/1.4950712 PMID: 27277049

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.

Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J

Brachytherapy201521 citations

DOI: 10.1016/j.brachy.2015.01.001 PMID: 25684438

Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy.

Spadinger I, Chu J, Afsari Golshan M, Keyes M, Pickles T, Hamm J, Morris WJ

Brachytherapy20156 citationsFirst author

DOI: 10.1016/j.brachy.2014.12.004 PMID: 25638507

Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals.

Keyes M, Miller S, Pickles T, Halperin R, Kwan W, Lapointe V, McKenzie M, Spadinger I, Pai H, Chan EK, Morris WJ

International journal of radiation oncology, biology, physics201458 citations

DOI: 10.1016/j.ijrobp.2014.06.037 PMID: 25151536

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival.

Lo AC, Morris WJ, Lapointe V, Hamm J, Keyes M, Pickles T, McKenzie M, Spadinger I

International journal of radiation oncology, biology, physics201458 citationsSenior author

DOI: 10.1016/j.ijrobp.2013.10.010 PMID: 24331654

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Ingrid Spadinger

Research

Latest papers

Latest funding

Cervical cancer patient reported gastrointestinal outcomes: intensity/volumetric modulated vs. 3D conformal radiation therapy.

After ASCENDE-RT: Biochemical and survival outcomes following combined external beam radiotherapy and low-dose-rate brachytherapy for high-risk and unfavourable intermediate-risk prostate cancer, a population-based analysis.

Prostate brachytherapy intraoperative dosimetry using a combination of radiographic seed localization with a C-arm and deformed ultrasound prostate contours.

Association of bladder dose with late urinary side effects in cervical cancer high-dose-rate brachytherapy.

Bladder accumulated dose in image-guided high-dose-rate brachytherapy for locally advanced cervical cancer and its relation to urinary toxicity.

Source strength verification and quality assurance of preloaded brachytherapy needles using a CMOS flat panel detector.

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.

Regional dose metrics as predictors of biochemical failure and local recurrence after low-dose-rate prostate brachytherapy.

Late urinary side effects 10 years after low-dose-rate prostate brachytherapy: population-based results from a multiphysician practice treating with a standardized protocol and uniform dosimetric goals.

Prostate-specific antigen at 4 to 5 years after low-dose-rate prostate brachytherapy is a strong predictor of disease-free survival.

Optimizing the Curative Treatment for High Risk Prostate Cancer: Combining Advanced Imaging, Trans-perineal Mapping Biopsies, and Dual Air Kerma Strength LDR Brachytherapy Implants to Minimize Radiation Dose to Normal Tissues

Frequent collaborators

Mira Keyes

Michael Mckenzie

Septimiu Salcudean

Winkle Kwan

Juanita Crook

Ghassan Hamarneh

Scott Tyldesley

Marc Gaudet

Robert Olson

Anna Tinker

Purang Abolmaesumi

David Palma

Dr. Olson

Michael Peacock